---
title: "Xarelto (rivaroxaban) in nonvalvular atrial fibrillation: Access and coverage questions"
description: "Access and coverage questions on Xarelto (rivaroxaban) in nonvalvular atrial fibrillation, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing. Questions: What are the NDC numbers for Xarelto 15 mg and 20 mg tablets? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/access-and-coverage"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xarelto (rivaroxaban) in nonvalvular atrial fibrillation: Access and coverage questions

Manufacturer: Janssen Pharmaceuticals, Inc.  
Prescribing information: [Xarelto](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf)

Access and coverage questions that apply to every indication of Xarelto are on [Xarelto (rivaroxaban), all indications: Access and coverage](https://www.evicenter.com/medical-information/xarelto/access-and-coverage).

## Access and billing

<a id="xarelto-ndc"></a>

### What are the NDC numbers for Xarelto 15 mg and 20 mg tablets?

> “15  mg tablets are round, red, biconvex film-coated tablets with a triangle 
> pointing down above a “15” marked on one side and “Xa” on the other side. 
> The tablets are supplied in the packages listed:
> NDC 50458-578-30	 Bottle containing 30 tablets
> NDC 50458-578-90	 Bottle containing 90 tablets
> NDC 50458-578-10 	 Blister package containing 100 tablets (10 blister cards 
> containing 10 tablets each)”

Source: [XARELTO: Prescribing information, page 21, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf#page=21)

> “20 mg tablets are triangle-shaped, dark red film-coated tablets with a triangle 
> pointing down above a “20” marked on one side and “Xa” on the other side. 
> The tablets are supplied in the packages listed:
> NDC 50458-579-30	 Bottle containing 30 tablets
> NDC 50458-579-90	 Bottle containing 90 tablets
> NDC 50458-579-89	 	Bulk bottle containing 1000 tablets
> NDC 50458-579-10 	 Blister package containing 100 tablets (10 blister cards 
> containing 10 tablets each)”

Source: [XARELTO: Prescribing information, page 21, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf#page=21)

Note: These are the strengths used for nonvalvular atrial fibrillation; section 16 of the Prescribing Information lists NDC numbers for the other strengths and presentations.

## Related pages
- [Medical information: Xarelto (rivaroxaban): Nonvalvular atrial fibrillation](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation)
- [Indication](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/safety)
- [Specific populations](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/dosing-and-administration)
- [Guidelines](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/guidelines)
